Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People registered with the Penn Medicine Primary Care Service Line
- People whose last two blood pressure readings from a clinic visit in the past 12 months showed a systolic (top number) reading of 140 or higher
- People who also meet at least one of the following conditions: a diagnosis of cardiovascular disease (heart attack, stroke, or related conditions); a calculated heart disease risk score of 10% or higher; a diagnosis of diabetes; a blood sugar (A1c) result of 6.5 or higher in the past year; being listed on a diabetes registry; or a cholesterol (LDL) reading of 190 or higher in the past five years
- People who are either not currently taking a cholesterol-lowering medication (statin or PCSK9 inhibitor or Inclisiran), or who are taking a low- or moderate-strength statin but still have an LDL cholesterol level above 100
Who may not be able to join:
- People currently taking PCSK9 inhibitor medications (a type of cholesterol-lowering injection)
- People who have a documented allergy or intolerance to statins on record with their doctor
- People who are currently pregnant
- People who are currently breastfeeding
- People with a serious condition that significantly shortens life expectancy, including: cancer that has spread to other parts of the body, enrollment in hospice care, end-stage kidney disease, severe heart failure, or dementia
- People who do not speak English and would need a translator
- People who do not have a cell phone
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kevin Volpp, MD, PhD, University of Pennsylvania
Phone: 215-746-4428
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in mean Systolic Blood Pressure (SBP); Difference in mean LDL-c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.